Cargando…
Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis
BACKGROUND: Ectopic pregnancy (EP) is an ectopic embryo implantation occurred outside the uterine cavity. Nowadays, more attention have garnered in fast and effective treatment with less side effects. Pristimerin is known as the clinical application for anti-cancer, and the effect on EP therapy is s...
Autores principales: | Shu, Chang, Yu, Xiaowei, Cheng, Shihuan, Jing, Jili, Hu, Cong, Pang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646443/ https://www.ncbi.nlm.nih.gov/pubmed/33173276 http://dx.doi.org/10.2147/DDDT.S274595 |
Ejemplares similares
-
Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
por: Cheng, Shihuan, et al.
Publicado: (2020) -
Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p
por: Li, Zaiyu, et al.
Publicado: (2019) -
MiR542-3p Regulates the Epithelial-Mesenchymal Transition by Directly Targeting BMP7 in NRK52e
por: Liu, Zhicheng, et al.
Publicado: (2015) -
miR-146a-5p-mediated suppression on trophoblast cell progression and epithelial-mesenchymal transition in preeclampsia
por: Peng, Pingping, et al.
Publicado: (2021) -
Antifungal Activity of Maytenin and Pristimerin
por: Gullo, Fernanda P., et al.
Publicado: (2012)